Hindusthan Insulators & Industries Ltd. Financial Update

Quarterly and Annual Performance

Hindusthan Insulators & Industries Limited announced its financial results for the quarter and year ended March 31, 2026. The company posted a standalone net profit of ₹20.91 crore for the March quarter.

However, the full financial year resulted in a net loss of ₹7.87 crore. This annual loss was heavily influenced by an exceptional charge of ₹47.05 crore related to the sale of its subsidiary, Hindusthan Speciality Chemicals Limited.

Shareholder Returns and Liquidity Boost

Despite the annual loss, the company's profitable quarter demonstrates operational resilience. Hindusthan Insulators is also rewarding shareholders with a final dividend of ₹0.50 per share and a significant 2:1 bonus share issue. This bonus ratio means shareholders will receive two new shares for every one share they currently hold, aimed at enhancing stock liquidity and investor interest.

Legal Disputes Affecting Results

The sale of Hindusthan Speciality Chemicals Limited has led to ongoing disputes with the buyer, DCM Shriram Limited. These disagreements primarily concern inventory verification and other claims. Consequently, ₹38.59 crore from the sale proceeds is being held in an escrow account with the State Bank of India.

A provision of ₹0.75 crore has been made to account for potential losses associated with these disputes.

Shareholder Benefits and Auditor Opinion

Shareholders are set to benefit from the announced dividend and bonus issue, pending necessary approvals. The bonus shares are expected to be credited by July 26, 2026, with the dividend's record date set for June 19, 2026.

Additionally, the company has re-appointed its internal auditors for the fiscal year 2026-27. Its statutory auditors provided an unmodified opinion on the annual financial results, indicating no significant concerns.

Key Risks for Investors

The primary risk facing investors is the unresolved litigation surrounding the subsidiary sale. The substantial amount held in escrow signals potential financial repercussions if the disputes are not settled favorably. The current provisions for losses might need adjustment depending on the litigation's outcome.

Contextual Financial Data

• Revenue from operations for the fourth quarter of FY26 reached ₹108.15 crore.
• The exceptional loss from the subsidiary sale was ₹47.05 crore.
• ₹38.59 crore remains in an escrow account related to the sale.

Future Focus for Investors

Investors should closely follow the progress of the litigation concerning the sale of Hindusthan Speciality Chemicals Limited. Future financial reports will be crucial for understanding the long-term impact of this transaction and the company's core operational performance. The effectiveness of the bonus share issue in improving market liquidity will also be a key area to monitor.